Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway-Reference-Cited by-同舟云学术

Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway

Published:2017-02-20 Issue:1 Volume:12 Page:
ISSN:1750-1326
Container-title:Molecular Neurodegeneration
language:en
Short-container-title:Mol Neurodegeneration

Author:

Portelius Erik,Mattsson Niklas,Pannee Josef,Zetterberg Henrik,Gisslén Magnus,Vanderstichele Hugo,Gkanatsiou Eleni,Crespi Gabriela A. N.,Parker Michael W.,Miles Luke A.,Gobom Johan^ORCID,Blennow Kaj

Funder

Royal Swedish Academy of Sciences

Wallströms och sjöbloms stiftelse

Gun och Bertil Stohnes Stiftelse

Magnus Bergwalls stiftelse

Demensförbundet

Stiftelsen för gamla tjänarinnor

National Health and Medical Research Council of Australia

The Mason Foundation

The Bethlehem Griffith Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13024-017-0152-5.pdf

Reference55 articles.

1. Back JW, Notenboom V, de Koning LJ, Muijsers AO, Sixma TK, de Koster CG, et al. Identification of cross-linked peptides for protein interaction studies using mass spectrometry and 18O labeling. Anal Chem. 2002;74(17):4417–22.

2. Bantscheff M, Dumpelfeld B, Kuster B. Femtomol sensitivity post-digest (18)O labeling for relative quantification of differential protein complex composition. Rapid Commun Mass Spectrom. 2004;18(8):869–76.

3. Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, et al. Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer’s disease. Curr Alzheimer Res. 2015;12(1):32–46.

4. Bjerke M, Portelius E, Minthon L, Wallin A, Anckarsater H, Anckarsater R, et al. “Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.” Int J Alzheimers Dis. 2010;2010:1–11.

5. Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368(9533):387–403.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-β deposition;Neuronal Signaling;2023-10-03

2. Blood biomarkers for Alzheimer’s disease in clinical practice and trials;Nature Aging;2023-05-18

3. Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force;The Journal of Prevention of Alzheimer's Disease;2023

4. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility;Nature Reviews Neurology;2022-05-18

5. Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis;Alzheimer's & Dementia;2022-01-27